Toronto, ON — AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing of a CAD$4.0 million financing round,
Allarta Life Science, a regenerative medicine company using novel hydrogels to enable cell-based therapies for type 1 diabetes (T1D), has received an award from JDRF, the leading global T1D research and advocacy organization.
ORIGINAL PRESS RELEASE, FACIT, September 28, 2022 Seed-stage commercialization realizes value in the Province’s health research and intellectual property September 28, 2022 – FACIT congratulates
Toronto, ON — AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing
Allarta Life Science, a regenerative medicine company using novel hydrogels to enable cell-based therapies for type 1 diabetes (T1D), has received an award from JDRF, the leading global T1D research and advocacy organization.
ORIGINAL PRESS RELEASE, FACIT, September 28, 2022 Seed-stage commercialization realizes value in the Province’s health research and intellectual property September
Get the latest updates delivered straight to your inbox! Stay notified about companies on the grow, the latest tech trends, funding news and opportunities, industry insights, upcoming events and more from across Hamilton and Halton’s innovation ecosystem.
